维普期刊资源整合服务平台（V6.5）

720篇 您的检索式：作者名="Slamon"

选中清除导出查看参考文献查看引证文献引用追踪共36页首页上一页第1页下一页末页 /36 跳转

	题名	作者	年代	出处	被引量
1	Amplification of c-erbB2 and aggressive breast cancer tumors 显示文摘	Slamon DJ Clark GM	1988	Science1988，240，4860：	2
2	Role of anthracycline- based therapy in the adjuvant treatment of breast cancer: Efficacy analyses determined by molecular subtypes of the disease 显示文摘	Slamon D J Mackey J Robert N	2007	Breast Cancer Res Treat2007，106，：	1
3	Overall survival advantage to simultaneous chemotherapy plus the humannized anti-HeR2 monoclonal antibody Herceptine in HER2 overexpressing metastatic breast cancer 显示文摘	Norton L Slamon D Leyland-Jones b	1999	Proc Am Soc Clin Oncol1999，18，：	1
4	The transmembrane Heregulin precursor is functionally active 显示文摘	Aguilar Z Slamon DJ	2001	J Bio Chem2001，276，44：	1
5	HER-2/neu signal transduction in human breast and ovarian cancer显示文摘	Reese D M Slamon D J	1997	Stem Cells1997，15，1：	1
6	Advances in adjuvant therapy for breast cancer显示文摘	Slamon DJ Romond EH Perez EA	2006	Clin Adv Hematol Oncol2006，4，37：	1
7	Human breast cancer correlation of relapse and survival with amplification of the HER-2/nen oncogene显示文摘	Slamon D Clark G Wong S	1987	Science1987，235，4875：	1
8	Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2显示文摘	Slamon DJ Leyland-Jones B Shak S	2001	N Engl J Med2001，344，11：	1
9	Use of chemotherapy plus a monoclonal antibody against I-IER2 for meta- static breast cancer that overexpresses HER2 显示文摘	SLAMON D J LEYLAND JONES B SHAK S	2001	N Engl J Med2001，344，11：	1
10	Human breast cancer: correlation of relapse and survival with amplifi- cation of the HER-2/neu oncogene显示文摘	Slamon DJ Clark GM Wong SG	1987	Science1987，235，4785：	1
11	Periostin promotes ovarian cancer angiogenesis and metastasis显示文摘	Min Zhu Marlena S. Fejzo Lee Anderson Judy Dering Charles Ginther Lillian Ramos Judith C. Gasson Beth Y. Karlan Dennis J. Slamon	2010	Gynecologic Oncology2010，，2：	1
12	Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer显示文摘	Slamon DJ Godolphin W Jones LA	1989	Science1989，244，4905：	1
13	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetax- el and trastuzumab (AC→TH) with docetaxel, carboplatin and trastu- zumab(TCH) in HER2 positive early breast cancer patients: BCIRG 006 study显示文摘	Slamon D Eiermann W Robert N	2006	Breast Cancer Res Treat2006，100，1：	1
14	Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene显示文摘	SLAMON D J CLARK G M WONG S G	1987	Science1987，235，4785：	1
15	Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that over expresses HER2 显示文摘	Slamon DJ Leyland Jones B Shak S	2001	Englned2001，，：	1
16	Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2显示文摘	Slamon DJ Leyland-Jones B Shak S	2001	N Engl J Med2001，，：	1
17	Studies of the Her-2/neu protocogene in human breast and ovaries cancer显示文摘	Slamon DJ Godophin W Ones Lh	1989	Science1989，244，4905：	1
18	Addition of herceptin (humanized anti-HER2 antibody ) to tirst line chemotherapy for HEP,2 overexpressing metastatic breast cancer ( HER2 +/MBC ) markedly increases anticancer activity: a randomized multinational controlled phase Ⅲ trial 显示文摘	Slamon D Leyland-Jones B Shak S	1998	Proc Am Soc Clin Oncol1998，377，17：	1
19	Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2显示文摘	Slamon DJ Leyland-Jones B Shak S	2001	N Engl J Med2001，344，11：	1
20	Expression of a multidrug-resis-tance gene in human tumors and tissues显示文摘	Fojo A T Uede K Slamon D J	1987	Proc Natl Acad Sci USA1987，84，1：	1

返回顶部每页显示：

共36页首页上一页第1页下一页末页 /36 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示